| 2026-03-23 |
KLNLSHAK0001253 |
HAINAN POLY PHARM CO LTD |
6224.0 kg |
848041.0
|
IOPAMIDOL INJECTION;VORICONAZOLE FOR INJECTION |
| 2026-03-08 |
KFUNA2601390656 |
ZHEJIANG POLY PHARM CO LTD |
4966.0 kg |
520300.0
|
FLUCONAZOLE OS (HTS: ),AMIODARONE HYDROCHLORIDE INJECTION (HTS: ) |
| 2026-03-06 |
DISYDCCN26020015 |
YICHANG HUMANWELL PHARMACEUTICAL CO |
6774.0 kg |
310420.0
|
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP |
| 2026-03-06 |
DISYDCCN26020016 |
AMTA LABS LIMITED |
5471.0 kg |
930400.0
|
DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES |
| 2026-02-28 |
KLNLSHAK0001211 |
HAINAN POLY PHARM CO LTD |
4724.0 kg |
848041.0
|
IOPAMIDOL INJECTION,VANCOMYCIN HYDROCHLORIDE FOR INJECTION,DOXYCYCLINE FOR INJECTION,DICYCLOMINE HYDROCHLORIDE INJECTION |
| 2026-02-14 |
KLNLSHAK0001193 |
HAINAN POLY PHARM CO LTD |
4435.0 kg |
848041.0
|
VANCOMYCIN HYDROCHLORIDE FOR INJECTION;TOBRAMYCIN FOR INJECTION;IOPAMIDOL INJECTION;GADOTERATE MEGLUMINE INJECTION |
| 2026-02-02 |
KLNLSHAK0001169 |
HAINAN POLY PHARM CO LTD |
4565.0 kg |
848041.0
|
VANCOMYCIN HYDROCHLORIDE FOR INJECTION |
| 2026-02-02 |
DISYDCCN25120034 |
YICHANG HUMANWELL PHARMACEUTICAL CO |
4870.0 kg |
310420.0
|
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP MEMANTINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES |
| 2026-02-02 |
DISYDCCN25120035 |
AMTA LABS LIMITED |
5006.0 kg |
930400.0
|
DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS TROSPIUM CHLORIDE EXTENDED-RELEASE CAPSULES DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES |
| 2026-01-26 |
KLNLSHAK0001158 |
HAINAN POLY PHARM CO LTD |
5811.0 kg |
848041.0
|
AZITHROMYCIN FOR INJECTION,VANCOMYCIN HYDROCHLORIDE FOR INJECTION |
| 2026-01-26 |
KLNLSHAK0001157 |
HAINAN POLY PHARM CO LTD |
6963.0 kg |
848041.0
|
DOBUTAMINE INJECTION,AZITHROMYCIN FOR INJECTION |
| 2026-01-26 |
DISYDCCN25120022 |
YICHANG HUMANWELL PHARMACEUTICAL CO |
8019.0 kg |
310510.0
|
GUANFACINE HYDROCHLORIDE EXTENDED-RELEASE TABLETS DESVENLAFAXINE EXTENDED-RELEASE TABLETS CILOSTAZOL TABLETS USP POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP |
| 2026-01-26 |
DISYDCCN25120023 |
AMTA LABS LIMITED |
1112.0 kg |
291229.0
|
DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES USP |
| 2026-01-15 |
KLNLSHAK0001145 |
HAINAN POLY PHARM CO LTD |
4321.0 kg |
280511.0
|
SODIUM NITROPRUSSIDE IN . % SODIUM CHLORIDE INJECTION,SODIUM NITROPRUSSIDE INJECTION,VANCOMYCIN HYDROCHLORIDE FOR INJECTION |
| 2026-01-04 |
DISYDCCN25110021 |
YICHANG HUMANWELL PHARMACEUTICAL CO |
3497.0 kg |
391400.0
|
CILOSTAZOL TABLETS USP POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP |
| 2026-01-04 |
DISYDCCN25110022 |
AMTA LABS LIMITED |
3153.0 kg |
930400.0
|
TROSPIUM CHLORIDE EXTENDED-RELEASE CAPSULES DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES |
| 2025-12-18 |
KLNLSHAK0001123 |
HAINAN POLY PHARM CO LTD |
5548.0 kg |
848041.0
|
AZITHROMYCIN FOR INJECTION,DOBUTAMINE INJECTION ,IOPAMIDOL INJECTION,DOXYCYCLINE FOR INJECTION |
| 2025-12-18 |
DISYDCCN25110006 |
YICHANG HUMANWELL PHARMACEUTICAL CO |
5525.0 kg |
310420.0
|
DESVENLAFAXINE EXTENDED-RELEASE TABLETS POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP |
| 2025-12-18 |
DISYDCCN25110010 |
AMTA LABS LIMITED |
4722.0 kg |
930400.0
|
TROSPIUM CHLORIDE EXTENDED-RELEASE CAPSULES DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS |
| 2025-12-18 |
DISYDCCN25110007 |
YICHANG HUMANWELL PHARMACEUTICAL CO |
10730.0 kg |
310420.0
|
GUANFACINE HYDROCHLORIDE EXTENDED-RELEASE TABLETS MEMANTINE HYDROCHLORIDE EXTENDED-RELEASECAPSULES POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP |
| 2025-12-05 |
DISYDCCN25100021 |
YICHANG HUMANWELL PHARMACEUTICAL CO |
12186.0 kg |
310420.0
|
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP |
| 2025-12-05 |
DISYDCCN25100026 |
AMTA LABS LIMITED |
2829.0 kg |
930400.0
|
DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS TROSPIUM CHLORIDE EXTENDED-RELEASE CAPSULES DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES |
| 2025-11-28 |
KLNLSHAK0001105 |
HAINAN POLY PHARM CO LTD |
4709.0 kg |
848041.0
|
VORICONAZOLE FOR INJECTION ,AZITHROMYCIN FOR INJECTION,VANCOMYCIN HYDROCHLORIDE FOR INJECTION |
| 2025-11-17 |
KLNLSHAK0001101 |
HAINAN POLY PHARM CO LTD |
6407.0 kg |
848041.0
|
SODIUM NITROPRUSSIDE IN . % SODIUM CHLORIDE INJECTION,DOBUTAMINE INJECTION,VANCOMYCIN HYDROCHLORIDE FOR INJECTION,GADOTERIDOL INJECTION |
| 2022-01-12 |
CHSL374210715WUH |
YICHANG HUMANWELL PHARMACEUTICAL CO |
9984.0 kg |
310420
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS REQUIRED TEMPERATURE 20 C |
| 2022-01-12 |
CHSL374210717WUH |
YICHANG HUMANWELL PHARMACEUTICAL CO |
11558.0 kg |
310420
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS REQUIRED TEMPERATURE 20 C HUMIDITY 50 |
| 2021-12-29 |
CHSL374210719WUH |
YICHANG HUMANWELL PHARMACEUTICAL CO |
9354.0 kg |
310510
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS DESVENLAFAXINE SUCCINATE EXTENDED-RELEASE TABLETS REQUIRED TEMPERATURE20 C HUMIDITY 60 |
| 2021-12-29 |
CHSL374210722WUH |
YICHANG HUMANWELL PHARMACEUTICAL CO |
11075.0 kg |
930400
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS MEMANTINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES REQUIRED TEMPERATURE 20 C HUMIDITY 60 |
| 2021-12-29 |
CHSL372738870WUH |
YICHANG HUMANWELL PHARMACEUTICAL CO |
10397.0 kg |
310510
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS DESVENLAFAXINE SUCCINATE EXTENDED-RELEASE TABLETS REQUIRED TEMPERATURE20 C HUMIDITY 60 |
| 2021-12-29 |
CHSL372739241WUH |
YICHANG HUMANWELL PHARMACEUTICAL CO |
11447.0 kg |
930400
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS MEMANTINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS DESVENLAFAXINE SUCCINATE EXTENDED-RELEASE TABLETS REQUIRED TEMPERATURE 20 C HUMIDITY 60 |
| 2021-12-20 |
AMAWSHHAKA100175 |
HAINAN POLY PHARM CO LTD |
7785.0 kg |
848041
|
GANCICLOVIR FOR INJECTION,AZITHROMYCIN FOR INJECTION |
| 2021-12-16 |
CHSL372738844WUH |
YICHANG HUMANWELL PHARMACEUTICAL CO |
13442.0 kg |
310420
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS REQUIRED TEMPERATURE 20 C HUMIDITY 60 |
| 2021-12-16 |
CHSL372110142WUH |
YICHANG HUMANWELL PHARMACEUTICAL CO |
16240.0 kg |
310420
|
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS REQUIRED TEMPERATURE 20 C HUMIDITY 60 |
| 2021-12-16 |
CHSL372110154WUH |
YICHANG HUMANWELL PHARMACEUTICAL CO |
11784.0 kg |
310420
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS REQUIRED TEMPERATURE 20 C HUMIDITY 60 |
| 2021-12-16 |
CHSL372738869WUH |
YICHANG HUMANWELL PHARMACEUTICAL CO |
9337.0 kg |
310510
|
CILOSTAZOL TABLETS POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS REQUIRED TEMPERATURE 20 C HUMIDITY 60 |
| 2021-12-13 |
AMAWA2110631002 |
YICHANG HUMANWELL PHARMACEUTICAL CO |
9782.0 kg |
310510
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS USP (XL) |
| 2021-12-07 |
CHSL368481577WUH |
YICHANG HUMANWELL PHARMACEUTICAL CO |
10091.0 kg |
903289
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS REQUIRED TEMPERATURE 20 C HUMIDITY 60 |
| 2021-12-07 |
CHSL368915563WUH |
YICHANG HUMANWELL PHARMACEUTICAL CO |
13106.0 kg |
310420
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS REQUIRED TEMPERATURE 20 C HUMIDITY 60 |
| 2021-12-07 |
CHSL368481581WUH |
YICHANG HUMANWELL PHARMACEUTICAL CO |
14095.0 kg |
310510
|
CILOSTAZOL TABLETS POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS REQUIRED TEMPERATURE 20 C HUMIDITY 60 |
| 2021-12-07 |
CHSL372109911WUH |
YICHANG HUMANWELL PHARMACEUTICAL CO |
6987.0 kg |
930400
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS MEMANTINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS REQUIRED TEMPERATURE20 C HUMIDITY 60 |
| 2021-12-07 |
CHSL372727804WUH |
AMTA LABS LIMITED |
1202.0 kg |
903289
|
TOLTERODINE TARTRATE EXTENDED-RELEASE CAPSULES REQUIRED TEMPERATURE 20 C HUMIDITY 60 |
| 2021-11-23 |
CHSL369764062WUH |
YICHANG HUMANWELL PHARMACEUTICAL CO |
15839.0 kg |
310420
|
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS REQUIRED TEMPERATURE 20 C |
| 2021-11-16 |
CHSL364340229WUH |
YICHANG HUMANWELL PHARMACEUTICAL CO |
17544.0 kg |
310510
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS DESVENLAFAXINE EXTENDED-RELEASE TABLETS |
| 2021-11-15 |
CHSL371918789WUH |
YICHANG HUMANWELL PHARMACEUTICAL CO |
14846.0 kg |
310420
|
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS REQUIRED TEMPERATURE 20 C |
| 2021-11-06 |
CHSL364339861WUH |
YICHANG HUMANWELL PHARMACEUTICAL CO |
10110.0 kg |
310510
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS DESVENLAFAXINE EXTENDED-RELEASE TABLETS REQUIRED TEMPERATURE 22 C |
| 2021-11-04 |
CHSL364339758WUH |
YICHANG HUMANWELL PHARMACEUTICAL CO |
8684.0 kg |
310510
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS DESVENLAFAXINE EXTENDED-RELEASE TABLETS REQUIRED TEMPERATURE 22 C |
| 2021-10-29 |
CHSL363505013WUH |
YICHANG HUMANWELL PHARMACEUTICAL CO |
11427.0 kg |
310510
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS REQUIRED TEMPERATURE 22 C |
| 2021-10-28 |
CHSL364192275WUH |
YICHANG HUMANWELL PHARMACEUTICAL CO |
11805.0 kg |
310510
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS REQUIRED TEMPERATURE 22 C |
| 2021-10-28 |
CHSL364339680WUH |
YICHANG HUMANWELL PHARMACEUTICAL CO |
18603.0 kg |
310510
|
BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS |
| 2021-10-16 |
CHSL360572000WUH |
YICHANG HUMANWELL PHARMACEUTICAL CO |
24486.0 kg |
310420
|
DESVENLAFAXINE EXTENDED-RELEASE TABLETS POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS |